A therosclerosis is an inflammatory disease of large artery walls, driven mainly by lipid peroxidant stress from oxidized low-density lipoprotein (OxLDL). 1 Intraplaque hemorrhage (IPH) is particularly important in promoting both atherosclerotic lesion progression and destabilization. 2 Thus, erythrocytes provide a potent combination of cholesterolenriched membrane lipids and heme-iron, which together pose a serious metabolic challenge in a pathology largely driven by oxidized cholesterols. 2 Along with intracranial hemorrhage, IPH is one of the most important examples of tissue damage due to extravasated blood. 2 Heme-iron is an effective peroxidant catalyst, through hydrogen peroxide coordination and Fenton chemistry 3 ; cholesterol is modified by peroxidation to potently cytotoxic and inflammatory oxysterols (5Ј, 6Ј-epoxycholesterol, 7Ј-ketocholesterol, and 21Ј-keto-cholesterol), 4 and macrophages are abundant in atherosclerosis and generate hydrogen peroxide when activated. The combination of cholesterol loading, heme/iron loading, and macrophage activation would therefore promote lipid peroxidation. 5 How monocytes entering plaques differentiate adaptively to clear hemorrhage-related iron and lipid may therefore be a key transcriptional decision in atherosclerosis.
Heme oxygenase-1 (HO-1) is a vital enzyme for iron homeostasis and protection from oxidant stress. It catalyzes pro-oxidant heme and generates biliverdin, free iron and carbon monoxide as reaction products. 6 HO-1 activity also stimulates upregulation of ferritin genes, leading to the safe chelation of iron. 6 Biliverdin is processed further to bilirubin, a direct antioxidant. 6 Like nitric oxide, low levels of carbon monoxide activate soluble guanylate cyclase to signal vascular protective responses. 6 For all these reasons, induction of HO-1 by heme provides a major pathophysiological homeostatic response in hemorrhage.
We have recently identified a unique state of macrophages in areas of hemorrhage within human atherosclerotic plaques that we originally designated HA-mac but have now renamed Mhem by analogy to M1, M2, and Mox states. 7 These cells have increased intracellular iron but are likely to be atheroprotective, as they show increased HO-1 expression, reduced oxidative stress, suppressed inflammatory activation, and increased release of the anti-inflammatory cytokine interleukin-10. 7 Furthermore, they do not show lipid accumulation of the type that defines foam cells. We have shown that the same state can be induced in human blood-derived monocytes in vitro by culturing in the presence of hemoglobin-haptoglobin complexes over 4 -8 days. 7 The in vitro generation of Mhem was found to be dependent on an autocrine loop involving release of the anti-inflammatory cytokine IL-10. 7 We have recently found that heme is the active stimulant for Mhem development, inducing HO-1 mRNA expression by a cycloheximidesensitive mechanism suggesting involvement of a transactivating protein. 8 Morphometric analysis of macrophages in atherosclerotic lesions with IPH showed that Mhem cells are distinct from classic lipid-laden macrophages and occupy separate microdomains. 7 This observation has a parallel in the standard pathological teaching that resolving hematomas contain distinct specialized macrophages containing either lipid (foam cells) or iron (siderophages). 2 The mechanisms regulating this functional specialization are not known. In this report, we have used transfection of human blood-derived monocytes with siRNA and plasmids, together with microarray analysis to identify activating transcription factor 1 (ATF-1) as a key transcription factor mediating heme-induced HO-1 expression. ATF-1 is a close but relatively little studied homolog of cyclic-3Ј-5Ј-adenosine monophosphate (cyclic-AMP, cAMP) binding protein (CREB1), and both mediate transcriptional activation by cyclic-AMP by binding to the cyclic-AMP response element (CRE). Importantly, we have found that ATF-1 also induces a program of gene expression responsible for lipid export, providing a mechanism explaining the reciprocal nature of iron and lipid handling by the cell. Together, these mechanisms may underlie homeostatic adaptation to IPH in macrophages.
Methods
A full version of the Methods is at http://circres.ahajournals.org/.
Cell Isolation and Culture
Peripheral blood-derived monocytes were purified and cultured from normal human volunteers as before, with informed consent and ethical clearance. 7 
Microarray and Quantitative PCR
Standard molecular biology methods were used. Macrophages were lysed, RNA-purified, and quality controlled, and then parallel aliquots were analyzed by both Agilent 4x44k and Affymetrix 1.0ST microarrays, following respective manufacturer's instructions. Results were validated by reverse-transcription quantitative polymerase chain reaction (qPCR). Microarrays were analyzed with Agilent GeneSpring GX10 and genelists exported to specialized bioinformatics programs. For selected genes, qPCR was done over a full-time course in a further 5 donors.
Western Analysis
Westerns blots were by amendment of our previous methods. 7 Cells were lysed and run by SDS-PAGE and blotted to PVDF using a commercial kit (Novex, Invitrogen). Blots were probed with multiple antibodies as indicated and visualized with ECLϩ and Hyperfilm (GE Healthcare).
Quantitative Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed following a minor amendment of published protocols. 9 Macrophages were fixed in 1% formaldehyde at 4°C for 5 minutes, stopped with excess glycine, lysed in nuclear lysis buffer AM-1, sheared by a 28-G needle 3 times (giving 1-kb fragments), and ChIP was carried out with the magnetic nonenzymatic kit (Active Motif) using Protein G beads (Invitrogen). Immunoprecipitates were DNA-purified, and quantitative (q)PCR was as above.
Quantification of ATF-1/DNA Binding
The 96-well plate assay for ATF-1 binding to promoter sequences was reverse-engineered from TransAm kit (Active Motif) for CREB1 activation (CREB1 and ATF-1 bind to a common motif). Oligos corresponding to human HO-1 and LXR-␤ enhancers or their ⌬ATF-1 mutants were bound to ELISA plates, macrophage lysates added, and ATF-1/DNA binding detected with anti-p-ATF-1 (Abcam). 
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Functional Assays
Oxidative stress assays were carried out as before, 7,8 using aminophenyl fluorescein a selective dye assay for hypochlorite, hydroxyl radicals, and peroxynitrite (Invitrogen). Cholesterol export was measured by a minor modification of established methods. 10 Macrophages were incubated with human recombinant ApoA1, an acceptor for cholesterol export, and cholesterol assayed with a specific high-sensitivity fluorescent kit (Invitrogen) as described. 11 Luciferase analysis was a Dual-Luciferase kit (Promega) and a 96-well luminometer (BioTek Synergy HT). For the foam cell assays, macrophages were cultured on tissue culture glass slides, challenged with Ox-LDL, stained with 10 mol/L Nile red (SigmaAldrich), and imaged by confocal microscopy (Zeiss LSM510), based on previous methods. 7
Results
Heme Induces HO-1 Through Activating Transcription Factor 1
Macrophages in atherosclerotic plaques tend to store either iron (siderophages) or lipid (foam cells) ( Figure 1A and 1B).
To investigate the mechanisms underlying this distinction further, we stimulated freshly isolated human blood-derived monocytes with heme and measured gene expression after 1 and 4 hours using microarray technology. Genes induced at 1 hour were generally only modestly upregulated and consisted mainly of signaling molecules and transcription factors (Figure 1C and Online Figures I through V). In contrast, those upregulated at 4 hours included a cluster of highly expressed effector genes such as HMOX1, the gene for HO-1 ( Figure  1D ). When genes induced at one hour were explored in more Tables I through III. detail using Gene Ontology, we found the most upregulated transcription factor to be activating transcription factor 1 (ATF-1) ( Figure 1E ). The most upregulated effector genes are shown in Figure 1F and Online Table I . In contrast, macrophage proinflammatory activation genes were consistently repressed (Online Figure VI) . The microarray data were corroborated with 2 microarray systems and with qPCR (Online Figure VII) . We then investigated the relationship between ATF-1 and HO-1 by qPCR in heme-stimulated monocytes from 5 additional donors. ATF-1 expression was transient and succeeded by a wave in HO-1 expression (Figure 2A ) with a concomitant high time-lagged correlation coefficient (Rϭ0.71, PϽ0.05). 12 Therefore, we tested the hypothesis that ATF-1 expression causally drives HO-1.
ATF-1 is known to be activated by phosphorylation at Ser63. By Western analysis, ATF-1 and p-Ser63-ATF-1 protein both peaked at about 4 hours after heme-stimulation, Figure 2F ) of an ATF-1-expressing plasmid into monocytes led to an increase in p-ATF-1 and HO-1 mRNA and protein ( Figure 2G, H) . Finally, transfection of ATF-1, but not unrelated plasmids or a Ser63-Ala nonphosphorylatable mu- tant (designated DN-ATF-1), also suppressed hROS ( Figure  2I ). In contrast, transfection of a close homolog of ATF-1, cAMP response element binding protein (CREB1), led to an increase in hROS ( Figure 2I ).
Heme Induces a Set of Genes Distinct From M1, M2, or Mox
Analysis of the microarray data using FDR-adjusted ANOVA showed that 2400 genes reached statistical significance. Therefore, further conservative cutoffs on fold-regulation (over 1.4-fold up or down) and intensity (above the level of known muscle-markers) were applied to exclude weakly regulated or poorly expressed genes. These more stringent criteria indicated that heme significantly modulated approximately 800 genes (Heatmap in Online Figure Table II ). The 44 genes in the Mhem / M1 intersection were counterregulated in Mhem and M1 (Online Table II Figure XII, D) . 7, 8 We found that in either M1 or M2 macrophages, heme did not increase CD163 expression (Online Figure XII, E) . As a control, we assessed the plasticity of M1 versus M2 commitment. We cultured human blood-derived macrophages with M1 and M2 stimuli for 3 days, swapped the stimuli, and carried out flow cytometry after another 3 days for a canonical M1-M2 marker macrophage mannose receptor (MMR) (Online Figure XII, F) . This indicated that MMR expression was conditioned by the initial Ͻ0.05 (a probability value adjusted for multiple simultaneous comparisons used in microarray analysis). As might be expected, the primary response gene set was enriched for transcription factors, signaling, and nucleotide metabolism. The secondary response gene set was enriched in genes coding for lipid handling, including lipid export and ␤-oxidation pathways. The largest single category was genes that are still not annotated. B, Genes extracted from microarray data using GO term "regulation of DNA dependent RNA transcription" were essentially transcription factors and ordered by fold induction by heme at 4 hours as indicated. ATF-1 is the most induced transcription factor. C, ATF-1-mediated gene regulatory network initiated by ATF-1-mediated coinduction of HO-1 and LXR-␤. Red nodes are gene induced by heme; green nodes, gene repressed by heme. Straight thick blue arrows, induction through cyclic-AMP response element (CRE). Curved thick blue arrow, self-inducing through CRE. Curved thick orange arrow, self-inducing through LXRE. Straight fine orange arrows, induction through LXRE, with either biochemical validation or bioinformatic prediction. Gray arrows, known dependences (PubMed) but exact mechanism uncertain. Green box, novel data. Known interactions are in the orange (lipid) and red (heme) boxes. This was inferred in silico by bioinformatic analysis of microarray data, qPCR data, siRNA data (Online Supplemental Methods). Of note, an ATF-1 site was identified upstream of ATF-1 itself, suggesting putative autoinduction. When added to macrophages, heme immediately induces hROS, before a later (biologically mediated) suppression. 8 We then examined whether heme-induced ATF-1 was mediated by heme-induced oxidative stress. We assessed a prototypical direct antioxidant (N-acetyl-cysteine, NAC; free radical scavenger) and prototypical indirect antioxidant (curcumin, anti-inflammatory and inducer of endogenous antioxidants). We first validated that NAC suppresses hROS in a cell-free system (Online Figure XIII, A) and then in macrophages (Online Figure XIII, B) . Both NAC and curcumin induced p-ATF-1 and suppressed additional hemeinduced p-ATF-1 (Online Figure XIII, C and D) . Because NAC suppresses hROS but induces p-ATF-1, it seems highly improbable that heme induces ATF-1 through a simple oxidant stress mechanism alone.
Heme Stimulates an ATF-1-Dependent Gene Regulatory Network That Coordinates Iron Handling With Lipid Handling
We then used standard cluster analysis methods to define secondary response genes induced by heme at 4 hours. When this cluster was analyzed by Gene Ontology (GO) classification to assign biological meaning, we unexpectedly found that it was significantly enriched in genes involved in lipid handling ( Figure 3A , listed in Online Table III and Online Figure XIV ). These included the transcription factor liver X receptor beta (LXR-␤), a "master regulator" of lipid metabolism ( Figure 3B) .
We extracted the regulatory sequences of each gene between human and mouse from the ENSEMBL database, identified conserved motifs, and analyzed these for transcription factor binding sites. Other than LXR-␤ itself (the ATF-1 responsive initiating gene), all of the key heme-inducible lipid handling genes had predicted LXR response elements ( Figure 3C ). We thus postulated that ATF-1 coinduces LXR-␤ and HO-1 and thereby directs a gene network that integrates lipid and iron handling ( Figure 3C ) and went on to test this linkage.
In time-course studies, ATF-1 preceded the largest part of the LXR-␤ rise ( Figure 4A ). Involvement of ATF-1 in LXR-␤ induction by heme was confirmed using ATF-1 siRNA ( Figure 4B and 4C) , and, again conversely, ATF-1-transfection induced LXR-␤ ( Figure 4D and 4E) . To exclude off-target effects, the siRNA data were corroborated with two siRNA oligos for ATF-1, 2 control oligos and pooled oligos (Dharmacon SMARTpool) as for ATF-1/HO-1, shown as previously in Online Figure IX ).
Heme and ATF-1 Transcriptionally Activate HO-1 and LXR Genes
To further test causality in this transcriptional network, we next assessed luciferase constructs. We first used an easily transfectable HEK cell line (not shown), which yielded more light-signal but obtained qualitatively similar results with human blood-derived monocytes, which were more physiologically relevant ( Figure 5 ). These we transfected with a series of luciferase constructs covering sequentially larger fragments of the 5-kb enhancer-promoter of HO-1 ( Figure 5A through 5C ). Heme-stimulation ( Figure 5B ) or ATF-1 cotransfection ( Figure 5C ) induced robust luciferase activity only with the full-length construct (Ϫ4.9 kb), but not with the shorter constructs (Ϫ2.2 kb and Ϫ0.3 kb), indicating a requirement for the enhancer sequence between Ϫ2.2 kb and Ϫ4.9 kb. ATF-1 is known to bind DNA through the cyclic-AMP response element (CRE): TGACGTCA, or its half-sites (TGACG/GTCA), 14 which is conserved in both HO-1 and LXR-␤ in both mouse and human (Online Figure XV) . As shown in Figure 5D , heme failed to activate the Ϫ4.9-kb reporter construct when containing a mutated ATF-1 response site (Ϫ4.9 ⌬ATF-1 mutant). A similar pattern was seen with ATF-1-cotransfection (not shown).
ATF-1 Binds to the Enhancers for the Genes for HO-1 and LXR-␤
We next tested whether ATF-1 binds to its predicted response elements in the HO-1 and LXR-␤ enhancers ( Figure 5E and 5F). ChIP is a method of detecting complexes between specific proteins and DNA sequences in live cells. Using an anti-p-ATF-1 antibody in a quantitative ChIP assay, we found that binding of p-ATF-1 to the ATF-1 site of the HO-1 enhancer was increased in human blood-derived monocytes approximately 10-fold 4 hours after heme stimulation, but not after only 1 hour ( Figure 5E ). Moreover, binding of p-ATF-1 to a proximal (Ϫ0.3 kb) control site in the HO-1 promoter was undetectable at either time point (not shown). Measurement by qPCR of the LXR-␤ enhancer promoter in the same ChIP samples also showed significant enrichment after heme treatment, although the peak of heme-stimulated p-ATF-1/ LXR-␤ binding was earlier, consistent with the earlier induc- tion of LXR-␤ mRNA ( Figure 5E ). Similar data were obtained with a solid phase assay quantifying p-ATF-1/DNA binding capacity. Immobilized oligonucleotides from HO-1 or LXR-␤ enhancers, but not the corresponding mutants with mutated ATF-1 response elements, captured more p-ATF-1 complexes from heme-stimulated blood-derived monocytes than controls ( Figure 5F ).
The Heme/ATF-1 Pathway Drives Lipid Export
Thus far, our bioinformatic data had suggested a coregulatory mechanism in which ATF-1 contributes to induction of LXR-␤ as well as HO-1, with each in turn driving many other genes regulating iron handling and lipid transport (Figure 3) . Consistent with the latter, time-course qPCR showed that ApoE expression followed LXR-␤ induction ( Figure 6A ). We also examined the predicted LXR-␤-responsive genes LXR-␣ and ABCA1 and found strong late induction of both LXR-target genes LXR-␣ and ABCA1 at 48 hours ( Figure 6B ). Hemeinduced ApoE was prevented by ATF-1 siRNA (Online Figure  XVI) . LXR-␤-specific siRNA was found to suppress levels of mRNA for both LXR-␣ and ABCA1 at 48 hours after heme stimulation, with Western blotting confirming the results for the latter at protein level (Online Figure XVII) . Furthermore, we found that heme and ATF-1 cotransfection both induced LXR-␣-luciferase plasmids at 48 hours ( Figure 6C ).
Because ABCA1 is a key cholesterol exporter to HDL, we next transfected ATF-1 or a control green fluorescent protein (GFP) construct into blood-derived monocytes to ask whether this pathway promoted cholesterol export, challenging the cells with OxLDL. We found that heme transfection suppressed cell-associated cholesterol ( Figure 6D ) and increased cholesterol efflux ( Figure 6E ), and both were prevented by ATF-1-siRNA ( Figure 6D and 6E) . Furthermore, ATF-1-transfected cells were resistant to foam cell formation when compared with controls ( Figure 6F and 6G) . These effects are similar to those induced by the LXR-agonist R-hydroxycholesterol and were inhibited by the LXR-antagonist S-hydroxycholesterol (not shown).
Mhem Macrophages in Human Intraplaque Hemorrhage Are Protected From Foam Cell Change and Coexpress p-ATF1, HO-1, and ABCA-1
Last, we went back to the human culprit plaques in which Mhem macrophages had first been described. 7 Because Mhem macrophages and foam cells are found in distinct zones, 7 we could easily reexamine the same cells in adjacent serial sections. We first compared the sizes of macrophages identified as Mhem with those identified as conventional inflammatory plaque macrophages and found that Mhem cells were smaller, consistent with resistance to foam cell Figure 6 . Heme directs foam cell protection through ATF-1. A and B, Bloodderived monocytes were stimulated with heme, after which mRNA levels for LXR-␤ were related to those for A, ApoE, or B, LXR-␣, ABCA1 and FASN (fatty acid synthase). ApoE succeeds and parallels LXR-␤ giving rise to a high time-lagged correlation coefficient (0.8). Likewise, LXR-␣ and canonical target ABCA1 have a very tight late temporal correlation, with induction of 10-to 20-fold at 48 hours. LXR-␤ shows an early peak, as detected by microarray, then falls and has second peak at 48 hours coincident with the LXR-␣ and ABCA1 spikes. FASN was not induced at any point. C, Heme-challenge and ATF-1 cotransfection produced equivalent induction of an LXR-␣ luciferase reporter construct at 48 hours; D and E, peripheral blood-derived monocytes were transfected with ATF-1 siRNA and then challenged with heme followed by OxLDL (10 g ⅐ mL
Ϫ1
). We then measured cholesterol accumulation (D) and cholesterol efflux (E) *PϽ0.05, paired t test. F, ATF-1 transfection induced protection against OxLDL-mediated foam cell formation. Human peripheral bloodderived monocytes were cultured for 48 hours, transfected with enhanced GFP or ATF-1. Cells were then incubated with OxLDL (hypochlorite-modified LDL 30 g ⅐ mL
) for 96 hours, after which they were fixed, stained for lipid with Nile red, and imaged by confocal microscopy. Figure 7A ). We found p-ATF-1 in Mhem macrophages but not in control foam cell macrophages with expanded cytoplasm due to accumulated lipid ( Figure 7B ). Furthermore, p-ATF-1 was nuclear in the Mhem macrophages, consistent with transcriptional activation ( Figure  7B ). Relative to the foam cells, the Mhem macrophages expressed increased HO-1, ABCA1, ApoE, and LXR-␤ ( Figure 7C and Online Figure XX to XXI) . Using 4-channel confocal, we then also formally showed there was colocalization of p-ATF-1 with HO-1 and ABCA1 ( Figure 7D) . Thus, our mechanistic insights are likely to apply to macrophages within vulnerable atherosclerotic plaques.
Discussion
Atherosclerosis, the main pathology causing cardiovascular morbidity and mortality, largely comprises macrophagemediated inflammation driven by oxidized lipids. The state of the infiltrating macrophages is a key pathophysiological determinant. IPH is pathogenic in advanced atherosclerosis through a combination of loading with iron, a lipid peroxidant, and erythrocyte membrane cholesterol. We have described a macrophage phenotypic adaptation to IPH that appears to partially counter its pathogenic effects. 7
Coordination of Lipid and Iron Homeostasis
We show that the hemorrhage-induced macrophage state is primarily directed by ATF-1-mediated coinduction of HO-1 and LXR-␤. Together, these coordinate the safe handling of iron in parallel with lipid export from the cell (Figure 8 ). The segregation of lipid storage in foamy macrophages versus iron storage in hemosiderin-laden macrophages makes functional sense as a strategy to help prevent iron-mediated lipid peroxidation. Heme/ATF-1-mediated coinduction of HO-1 and LXR-␤ provides a molecular mechanism for this phenomenon. We defined this pathway by genetic modification of blood-derived monocytes from normal human volunteers to allow both pathophysiological relevance and specific molecular control.
Pathophysiological Relevance of the Model
The in vitro model of challenge with 10 mol/L heme is physiologically relevant, being approximately 1/40th of that measured in subarachnoid hematoma in vivo. 15 Furthermore, recent transcriptome analyses of plaque macrophages and pooled cell line microarray data indicate that gene expression in freshly isolated blood-derived monocytes is relevant to plaques, in sharp contrast to gene expression in transformed cell lines. 16, 17 Indeed, the macrophage cell lines we have examined (eg, U937, THP-1, RAW264) have constitutively expressed very high levels of p-ATF-1, consistent with its role as a proto-oncogene 18 (not shown). Thus, although human blood monocytes are difficult to transfect, they are likely to be to be far more informative about human pathophysiology. Of note, siRNA is in essence a perturbation experiment and thus useful even in the absence of complete knockout. 19 
Mhem Macrophages Mitigate Accelerant Effects of Intraplaque Hemorrhage
The macrophage state we are now defining as Mhem was first described associated with human fatal coronary intraplaque hemorrhages (hemorrhage-associated macrophages, HA-mac). 7 These had less oxidative stress than foamy macrophages-in Macrophages ingest erythrocytes (RBC), which are then trafficked to the lysosome (Ly). 8 Within the lysosome, heme is released causing "heme stress," which is associated with oxidative stress 8 but causes a more complex response ( Figure XIII) . Heme stress induces and causes phosphorylation of ATF-1. Heme stress activates Nrf2 in parallel. 8 ATF-1 translocates to the nucleus (blue arrows) and binds to the enhancers of key transcription factors (HO-1 and LXR) and drives transcription of genes (fine arrows), leading to heme disposal into ferritin (HO-1/Fe pathway), releasing biliverdin (green) and bilirubin (orange) to diffuse out the cell. In parallel, (second gene icon) ATF-1 induces cholesterol export through ABCA-1 (membrane cylinder), driving local HDL synthesis and reverse cholesterol transport (HDL is essentially cholesterol docked onto ApoA). Thus, iron and lipid handling are linked through ATF-1. This explains the histological dichotomy between lipid-laden macrophages and iron-laden macrophages and also points to key therapeutic avenues linking antioxidant protection, antiinflammatory protection, and foam cell protection.
the face of increased iron storage; higher HO-1 expression; less myeloperoxidase expression; and higher IL-10 expression. We modeled these in vitro and found that hemoglobin-:haptoglobin complexes evoked cells with similar characteristics, switched by an autocrine IL-10/CD163 feedback loop. 7 These cleared Hb more quickly than control macrophages, and we proposed that they were adaptively differentiated to mitigate the otherwise accelerant effects of intraplaque hemorrhage on plaque development. We now show that the initiating transcriptional events involve induction and phosphorylation and ATF-1 and subsequent coinduction of an HO-1 cascade and an LXR/ABCA1/ApoE/foam cell protection cascade. The HA-mac/Mhem cells in intraplaque hemorrhage indeed coexpress p-ATF-1, HO-1, and the canonical LXR targets ApoE and ABCA1 and have less foam cell change, a feature we did not actively comment on before in the absence of mechanistic evidence.
Cyclic-AMP Response Element-Mediated Regulation of Vascular Disease
ATF-1 is named for activating transcription in response to cyclic-AMP. 20 Its nearest homolog, cAMP response element binding protein (CREB) has been much more extensively studied and is thought to be the major cAMP activated transcription factor, regulating key metabolic genes, for example, gluconeogenesis [21] [22] [23] and lipoprotein lipase. 24 Interestingly, Ruffell et al described dependency of woundresolving macrophages on CREB, with a targeted inactivating mutation of its response element in a single target gene preventing in vivo healing, 25 setting a precedent for a role of the CREB family in macrophage differentiation. Similarly, the cytoprotective role of ATF-1 that we describe has precedents in prosurvival and mitogenic effects in other lineages. 18,26 -29 In contrast to ATF-1-dependent cytoprotection in human blood monocytes, ATF-1 suppresses induction of ferritin heavy chain and the HO-1 gene through antioxidant response elements in HEK cells. 30 Again in HEK cells, CREB-1 binding to the cyclic-AMP response element at ϷϪ4 kb mediates the induction of HO-1 by the oxylipid nitrolinoleic acid. 31 Here, we found an alternative use of the same response element (GTCA) in mediating heme-induced HO-1. As there has been little attention paid to determining how heme induces HO-1, 6 the identification of the mechanism of this important physiological negative feedback loop is highly significant.
LXRs in Vascular Disease
Atherosclerosis is thought to largely hinge on phagocytosis of OxLDL by plaque macrophages through scavenger receptors, 32 causing proinflammatory activation, endoplasmic reticulum stress, and oxidant stress, promoting death and necrotic core formation. 33 However, macrophages also protect against inflammatory activation and lipid overload by lipid export to high-density lipoprotein (HDL) in reverse cholesterol transport, 34 through adenosine-triphosphatebinding-cassette-transporter (ABC) proteins -A1 and -G1. 34 ABCA1 and ABCG1 are upregulated by LXRs, former orphan nuclear receptors ligated by oxysterols and by cholesterol at "overload" concentrations. 2, 5, 35, 36 Thus LXRs sense cholesterol overload and cholesterol oxidation and negatively feedback to evoke cholesterol export and suppress inflammatory activation. 37 Hemorrhage/heme-challenge feeds forward into this key defense through a novel heme3 ATF-13 LXR-␤3 LXR-␣ cascade. Notably, in a landmark paper, peroxisome proliferation activation receptor ␥ (PPAR-␥) induced lipid export through transcriptional induction of LXR-␣. 35 The heme3 ATF-1 pathway in our study induced greater foldchange in LXR-␣ mRNA (11-fold) than was previously observed through PPAR-␥ (5-fold). 35 Moreover, this appears to be the first documentation of LXR-␤ isoform induction by any stimulus. The magnitude of effect of heme3 ATF-1 on cholesterol efflux is similar to that in the PPAR-␥3 LXR3 ABCA1 axis 35 and comparable to differences between normal versus ABCG-deficient mice. 38, 39 The heme3 ATF-13 LXR-␤ cascade was devoid of induction of fatty acid synthesis genes, a major side-effect of some pharmacological LXR agonists that is through LXR-␣ activation, [41] [42] [43] [44] suggesting that heme3 ATF-13 LXR-␤ mediated activation may be more beneficial.
Macrophage Polarization
The Mhem anti-inflammatory state appears to be a polar opposite of the recently described M1-like iron-overload state that impairs wound healing. 45 We suspect that this is what ATF-1 protects against, and therefore ATF-1-deficient mice may not cope with hemorrhage. 46 However, this is an area of active investigation beyond the scope of the current report. Although plaque M2 macrophages may overexpress PPAR-␥, which also may induce LXR-␣, our data indicate that Mhem is very distinct from an M2 state. 47 Furthermore, although Leitinger's group recently described a HO-1-expressing putatively protective mouse macrophage state Mox driven by oxidized phospholipids through Nrf2, 13 transcriptome comparisons indicate that Mhem are not Mox. However, we have shown elsewhere that Nrf2 plays a role in heme-induced HO-1. 8 It is possible therefore that ATF-1 and Nrf2 may be cooperative in HO-1 induction, as seen for NFB/AP-1 cooperativity in macrophage responses to minimally modified LDL. 48 The ATF-1 site immediately adjacent to a putative Bach/Nrf2 site (Online Figure XVIII) , so cooperative binding would be plausible. Moreover, ATF-1 and Nrf2 are structurally related, basic zipper transcription factors, raising the more speculative hypothesis of ATF-1/Nrf2 heterodimerization. Extending the idea of transcription factor cooperativity more globally, we found by bioinformatic prediction from ChIP-Seq databases, overrepresentation of up to 10 transcription factor binding sites in the Mhem geneset (Online Figure XIX) . This sets ATF-1 in a context of a more complex response comprising a network of several transcriptional factors that may modulate responses.
As far as can be assessed without a very large (and largely repetitious) microarray experiment, Mhem appear to be distinct to recognized polarization patterns (M1, M2, Mox). Both M1 and M2 were HLA-DR-high activation states distinct to the HLA-DR-low Mhem state and either M1 or M2 commitment prevented acquisition of a full Mhem state. However, both M1 and M2 cells committed relative to one another could be dynamically converted to HLA-DR-low by heme-treatment, suggesting that the activation-deactivation axis may show some plasticity. Interestingly, M1 or foam cell differentiation both enhanced heme-induced p-ATF-1 responses, whereas M2 or Mox differentiation suppressed both basal and heme-stimulated p-ATF-1. Furthermore, two2 relevant antioxidants, NAC (a prototypical direct antioxidant, ie, free radical scavenger) and curcumin (a prototypical indirect antioxidant and nutriceutical): both induced p-ATF-1 and prevented heme from inducing it any further. Although these data suggest that ATF-1 may also play a role in the mechanism of action of these important agents, testing this was beyond the scope of the current report. Venn diagrams identified a large number of apparently Mhem specific genes, the most fold regulated and highly expressed was HTRA3, which could be assessed as a useful Mhem marker in future.
What Kinases Mediate ATF-1 Regulation by Heme?
Although a study of heme-regulated ATF-1 kinases was beyond the scope of the present report, heme-induced ATF-1 could be activated by several serine kinases: protein kinase A 14 ; several stress kinases including adenosine monophosphate activated kinase (AMPK) in skeletal muscle during exercise, 49 p38 mitogen-activated protein kinase in leptin signaling, 50 salt-inducible kinase/mitogen stress-activated kinase (SIK/MSK) downstream of ultraviolet light, 51, 52 and by protein kinase D. 53 Tyrosine phosphorylation of ATF-1 by homeodomain interacting protein kinase (HIPK) has also been described in response to genotoxic stress. 54 Understanding the role of upstream kinases in the regulation of Mhem is a major priority for further work because of its potential for experimental and eventual therapeutic modulation by small molecules.
Therapeutic Potential
LXR agonists are being actively developed to initiate reverse cholesterol transport, 41 and HO-1 is a target of interest for a variety of existing therapies. 6 Considering that there is significant therapeutic interest in each of the mediators alone, our finding that ATF-1 coregulates HO-1 and LXR suggests that therapeutic manipulation of p-ATF-1 may provide a strong benefit/risk ratio in atherosclerosis. In this light, our findings that p-ATF-1 is induced by curcumin (a dietary flavonoid) 55 and NAC (established treatment for paracetamol overdose and interstitial lung disease) 56 is interesting.
Conclusions
In conclusion, Mhem is an atheroprotective macrophage state, distinct from M1, M2, and Mox, that develops in specific adaptation to IPH. Induction of ATF-1 coinduces HO-1 and LXR-␤, interlinking lipid and iron handling for the first time. By acting as a novel transcriptional integrator of iron and lipid homeostasis, ATF-1 is a key driver of human plaque monocytes to acquire the atheroprotective Mhem macrophage state.
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